Cargando…
Favipiravir in Kidney Transplant Recipients With COVID-19: A Romanian Case Series
BACKGROUND: Favipiravir (FPV) is an orally administrable antiviral drug that selectively inhibits RNA-dependent RNA polymerase and has been repurposed for COVID-19 treatment. There is limited information on the use of FPV in kidney transplant recipients (KTx), who often have multiple comorbidities a...
Autores principales: | Cismaru, Cristina, Elec, Alina Daciana, Muntean, Adriana, Moisoiu, Tudor, Lupșe, Mihaela, Antal, Oana, Elec, Florin Ioan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719939/ https://www.ncbi.nlm.nih.gov/pubmed/35065831 http://dx.doi.org/10.1016/j.transproceed.2021.12.011 |
Ejemplares similares
-
COVID-19 and kidney transplantation: the impact of remdesivir on renal function and outcome - a retrospective cohort study
por: Elec, Florin, et al.
Publicado: (2022) -
The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report
por: Antal, Oana, et al.
Publicado: (2023) -
COVID-19 after kidney transplantation: Early outcomes and renal function following antiviral treatment
por: Elec, Alina Daciana, et al.
Publicado: (2021) -
An Integrated Approach Using HLAMatchmaker and Pirche II for Epitopic Matching in Pediatric Kidney Transplant—A Romanian Single-Center Study
por: Aldea, Paul Luchian, et al.
Publicado: (2023) -
First Reported Case in Romania of a Successfully Treated Severe COVID-19 in a Kidney Transplant Recipient: A Focus on Acute Kidney Injury
por: Tosa, Flaviu, et al.
Publicado: (2020)